The Food Safety and Drug Administration (FSDA) has uncovered an alleged fake billing network linked to the illegal pharmaceutical trade in Uttar Pradesh, seizing medicines worth ₹15.50 lakh during a major enforcement drive. The operation, carried out at multiple locations in Lucknow, including Aminabad, resulted in the sealing of several drug firms, while samples of suspected medicines have been sent to a government laboratory for testing. Preliminary findings indicate that an organised network was generating fake invoices without any actual supply of medicines, using paper transactions to facilitate the distribution of suspected and counterfeit drugs.
A joint team of 18 drug inspectors conducted extensive raids across Aminabad and nearby areas on Friday. More than 13 pharmaceutical firms were inspected, with officials examining stock registers, billing records and other business documents. During the operation, medicines worth ₹15.50 lakh were recovered from an illegal warehouse and immediately seized. Officials believe the action could help expose a much larger network involved in illegal pharmaceutical operations across the state.
According to the investigation, the syndicate allegedly prepared fake invoices without supplying medicines. No genuine transfer of funds took place through the bank accounts involved, and there was no physical movement of pharmaceutical products. Despite this, documents showing fictitious purchases and sales were created to project legitimate business transactions. Authorities suspect these fabricated records were used to support the circulation of counterfeit and suspicious medicines while also facilitating tax evasion and violations of pharmaceutical licensing regulations.
During the raids, officials searched an illegal warehouse operated by Mishra Associates in Aminabad, where a large quantity of medicines was seized. Five samples of suspected medicines collected from the premises have been sent to a government laboratory for quality testing. In addition, authorities have launched a detailed examination of billing records, stock registers, purchase invoices and account books of other firms linked to the network. Pending completion of the investigation, the purchase, sale and business operations of the concerned firms have been suspended.
As part of the wider operation, the FSDA collected a total of 32 medicine samples from different locations for laboratory analysis. If the samples fail to meet prescribed quality standards or are confirmed to be counterfeit, the licences of the concerned firms will be cancelled. Authorities have also indicated that further legal action will be initiated under the Drugs and Cosmetics Act and other applicable laws.
The firms sealed during the operation include Mishra Associates, Sonal Pharma, Shri Ashok Pharmaceuticals, SKG Medicals, Gayatri Pharma & Surgical, Mishra Medical Agency (Bachhrawan), Vidya Pharm, Health Plus, and MK Pharma, among others. Officials are continuing to examine documents and stock records from these establishments. Directions have also been issued to register criminal cases against the operators found responsible for the alleged violations.
The FSDA said the objective of the operation extends beyond exposing fake billing practices and is aimed at dismantling an interstate network dealing in counterfeit medicines. Investigators are now trying to determine the geographical spread of the racket and identify the wholesale drug dealers, agents and other individuals involved. Officials believe that scrutiny of financial records and business documents will help reveal the full extent of the network.
Experts from the pharmaceutical sector warn that fake billing and counterfeit medicines pose a serious threat to public health. Such products can compromise medical treatment and endanger patients’ lives. They emphasise that regular monitoring of the pharmaceutical supply chain, digital tracking of medicine movement, periodic audits of licensed drug firms and strict legal action against offenders are essential to preventing organised pharmaceutical fraud and protecting public health.
